FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045450835> ?p ?o ?g. }

• W2045450835 endingPage "2050" @default.
• W2045450835 startingPage "2041" @default.
• W2045450835 abstract "To compare treatment outcomes by starting CD4 cell counts using data from the Comprehensive International Program of Research on AIDS-South Africa trial.An observational cohort study.Patients presenting to primary care clinics with CD4 cell counts below 350 cells/microl were randomized to either doctor or nurse-managed HIV care and followed for at least 2 years after antiretroviral therapy (ART) initiation. Clinical and laboratory outcomes were compared by baseline CD4 cell counts.Eight hundred and twelve patients were followed for a median of 27.5 months and 36% initiated ART with a CD4 cell count above 200 cells/microl. Although 10% of patients failed virologically, the risk was nearly double among those with a CD4 cell count of 200 cells/microl or less vs. above 200 cells/microl (12.2 vs. 6.8%). Twenty-one deaths occurred, with a five-fold increased risk for the low CD4 cell count group (3.7 vs. 0.7%). After adjustment, those with a CD4 cell count of 200 cells/microl had twice the risk of death/virologic failure [hazard ratio 1.9; 95% confidence interval (CI), 1.1-3.3] and twice the risk of incident tuberculosis (hazard ratio 1.90; 95% CI, 0.89-4.04) as those above 200 cells/microl. Those with either a CD4 cell count of 200 cells/microl or less (hazard ratio 2.1; 95% CI, 1.2-3.8) or a WHO IV condition (hazard ratio 2.9; 95% CI, 0.93-8.8) alone had a two-to-three-fold increased risk of death/virologic failure vs. those with neither, but those with both conditions had a four-fold increased risk (hazard ratio 3.9; 95% CI, 1.9-8.1). We observed some decreased loss to follow-up among those initiating ART at less than 200 cells/microl (hazard ratio 0.79; 95% CI, 0.50-1.25).Patients initiating ART with higher CD4 cell counts had reduced mortality, tuberculosis and less virologic failure than those initiated at lower CD4 cell counts. Our data support increasing CD4 cell count eligibility criteria for ART initiation." @default.
• W2045450835 created "2016-06-24" @default.
• W2045450835 creator A5012911024 @default.
• W2045450835 creator A5032374309 @default.
• W2045450835 creator A5034474153 @default.
• W2045450835 creator A5037592415 @default.
• W2045450835 creator A5040572250 @default.
• W2045450835 creator A5051991963 @default.
• W2045450835 creator A5053554717 @default.
• W2045450835 creator A5064614188 @default.
• W2045450835 creator A5072946962 @default.
• W2045450835 creator A5074213191 @default.
• W2045450835 creator A5078852155 @default.
• W2045450835 date "2010-08-24" @default.
• W2045450835 modified "2023-10-02" @default.
• W2045450835 title "Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/μl is associated with improved treatment outcomes in South Africa" @default.
• W2045450835 cites W1574092316 @default.
• W2045450835 cites W1735143085 @default.
• W2045450835 cites W1889532030 @default.
• W2045450835 cites W1971927429 @default.
• W2045450835 cites W1998151345 @default.
• W2045450835 cites W1999408007 @default.
• W2045450835 cites W2016264635 @default.
• W2045450835 cites W2017793579 @default.
• W2045450835 cites W2034321374 @default.
• W2045450835 cites W2035440729 @default.
• W2045450835 cites W2039602199 @default.
• W2045450835 cites W2064871165 @default.
• W2045450835 cites W2065293221 @default.
• W2045450835 cites W2083754882 @default.
• W2045450835 cites W2098571076 @default.
• W2045450835 cites W2143265231 @default.
• W2045450835 cites W2160888326 @default.
• W2045450835 cites W2162453648 @default.
• W2045450835 cites W2171081019 @default.
• W2045450835 cites W2182777591 @default.
• W2045450835 cites W2615187673 @default.
• W2045450835 doi "https://doi.org/10.1097/qad.0b013e32833c703e" @default.
• W2045450835 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2914833" @default.
• W2045450835 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20613459" @default.
• W2045450835 hasPublicationYear "2010" @default.
• W2045450835 type Work @default.
• W2045450835 sameAs 2045450835 @default.
• W2045450835 citedByCount "61" @default.
• W2045450835 countsByYear W20454508352012 @default.
• W2045450835 countsByYear W20454508352013 @default.
• W2045450835 countsByYear W20454508352014 @default.
• W2045450835 countsByYear W20454508352015 @default.
• W2045450835 countsByYear W20454508352016 @default.
• W2045450835 countsByYear W20454508352017 @default.
• W2045450835 countsByYear W20454508352018 @default.
• W2045450835 countsByYear W20454508352019 @default.
• W2045450835 countsByYear W20454508352020 @default.
• W2045450835 countsByYear W20454508352022 @default.
• W2045450835 crossrefType "journal-article" @default.
• W2045450835 hasAuthorship W2045450835A5012911024 @default.
• W2045450835 hasAuthorship W2045450835A5032374309 @default.
• W2045450835 hasAuthorship W2045450835A5034474153 @default.
• W2045450835 hasAuthorship W2045450835A5037592415 @default.
• W2045450835 hasAuthorship W2045450835A5040572250 @default.
• W2045450835 hasAuthorship W2045450835A5051991963 @default.
• W2045450835 hasAuthorship W2045450835A5053554717 @default.
• W2045450835 hasAuthorship W2045450835A5064614188 @default.
• W2045450835 hasAuthorship W2045450835A5072946962 @default.
• W2045450835 hasAuthorship W2045450835A5074213191 @default.
• W2045450835 hasAuthorship W2045450835A5078852155 @default.
• W2045450835 hasBestOaLocation W20454508351 @default.
• W2045450835 hasConcept C126322002 @default.
• W2045450835 hasConcept C141071460 @default.
• W2045450835 hasConcept C201903717 @default.
• W2045450835 hasConcept C203014093 @default.
• W2045450835 hasConcept C207103383 @default.
• W2045450835 hasConcept C44249647 @default.
• W2045450835 hasConcept C71924100 @default.
• W2045450835 hasConcept C72563966 @default.
• W2045450835 hasConcept C90924648 @default.
• W2045450835 hasConceptScore W2045450835C126322002 @default.
• W2045450835 hasConceptScore W2045450835C141071460 @default.
• W2045450835 hasConceptScore W2045450835C201903717 @default.
• W2045450835 hasConceptScore W2045450835C203014093 @default.
• W2045450835 hasConceptScore W2045450835C207103383 @default.
• W2045450835 hasConceptScore W2045450835C44249647 @default.
• W2045450835 hasConceptScore W2045450835C71924100 @default.
• W2045450835 hasConceptScore W2045450835C72563966 @default.
• W2045450835 hasConceptScore W2045450835C90924648 @default.
• W2045450835 hasIssue "13" @default.
• W2045450835 hasLocation W20454508351 @default.
• W2045450835 hasLocation W20454508352 @default.
• W2045450835 hasLocation W20454508353 @default.
• W2045450835 hasLocation W20454508354 @default.
• W2045450835 hasLocation W20454508355 @default.
• W2045450835 hasOpenAccess W2045450835 @default.
• W2045450835 hasPrimaryLocation W20454508351 @default.
• W2045450835 hasRelatedWork W1516595110 @default.
• W2045450835 hasRelatedWork W2026094606 @default.
• W2045450835 hasRelatedWork W2071306276 @default.
• W2045450835 hasRelatedWork W2095296120 @default.
• W2045450835 hasRelatedWork W2117842875 @default.

• next